HIT Consultant September 14, 2021
Fred Pennic

What You Should Know:

Lightstone Ventures today announced the closing of Lightstone Ventures III with $375M in capital commitments, to invest in early-stage companies developing high-impact therapeutics and technologies.

– The new fund was oversubscribed, exceeding the firm’s targeted raise, and included strong support from both new and existing limited partners. With the closing Fund III, Lightstone Ventures also announced the appointments of Christina Isacson, Ph.D., as Partner...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Medical Devices, Pharma / Biotech, Trends
Regeneron launches $500m venture capital arm
Elevance Health And Private Equity Firm To Invest In Primary Care
AI-driven eQMS company Dot Compliance scores $17M
Nine UCL researchers secure £560m in research funding from ERC
Scoop: Andreessen Horowitz closes $7.2 billion for new funds

Share This Article